for clinical purposes , a serum pepsinogen a/pepsinogen c ratio less than 1.8 is the most suitable test , with a sensitivity of 74 % and a specificity of 76 % for gastric cancer or its precursors , with a reference population of patients with benign gastric disorders .
C0024623
gastric
C0038351
gastric